Fundraising FoxNoumea Biosciences
Boston, US · Founded 2022 · Delaware corporation
Find your way into Noumea Biosciences
Sign up to see every warm intro you have to Noumea Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Noumea Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Noumea Biosciences is a biotechnology company developing a therapeutic platform. It is based in Boston.
Founders & leadership
MB
Matthew BlumNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$300K disclosed across 1 round · 2022
▶$300KraisedSep 2022 · 1 investors · BiotechnologyRule 506(b)
▶$300KraisedSep 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew BlumExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $300K
- Minimum investment
- $300K
- Proceeds to insiders
- $85K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Noumea Biosciences do?
- Noumea Biosciences is a biotechnology company developing a therapeutic platform. It is based in Boston.
- How much funding has Noumea Biosciences raised?
- Noumea Biosciences has disclosed $300K raised across 1 round.
- Where is Noumea Biosciences headquartered?
- Noumea Biosciences is headquartered in Boston, US.